期刊文献+

^(18)F-FDG PET/CT诊断继发性噬血细胞综合征原发病因 被引量:2

^(18)F-FDG PET/CT in diagnosing the primary disease of secondary hemophagocytic syndrome
下载PDF
导出
摘要 目的探讨18F-FDG PET/CT诊断继发性噬血细胞综合征原发病因的价值。方法回顾性分析19例继发性噬血细胞综合征患者的18F-FDG PET/CT资料,将诊断结果与临床诊断结果进行对比;采用18 F-FDG PET/CT监测3例淋巴瘤相关噬血细胞综合征疾病进展。结果 13例18F-FDG PET/CT提示为恶性淋巴瘤,表现为多发淋巴结、脾脏或骨髓高代谢灶,其中9例确诊为非霍奇金淋巴瘤,4例诊断不明;6例18F-FDG PET/CT未提示恶性肿瘤,其中2例确诊为系统性红斑狼疮、1例确诊为EB病毒感染、1例确诊为溃疡性结肠炎、1例确诊为成人斯蒂尔病,1例病因不明。3例淋巴瘤相关噬血细胞综合征患者病情改善时18 F-FDG PET/CT示原高代谢灶消失,疾病复发时出现新的高代谢病灶。结论18F-FDG PET/CT对于早期诊断继发性噬血细胞综合征的病因、尤其是鉴别疾病良恶性具有重要价值,亦可监测原发病进展情况。 Objective To explore the value of 18 F-FDG PET/CT in diagnosing the primary disease of secondary hemophagocytic syndrome. Methods ^18F-FDG PET/CT data of 19 patients with secondary hemophagocytic syndrome were retrospectively analyzed, and the outcomes were compared with clinical results. The situation of 3 cases with lymphoma-associatied hemophagocytic syndrome was monitored with ^18F-FDG PET/CT. Results Malignant lymphoma was indicted in 13 patients by ^18F-FDG PET/CT, which presenting as high metabolic lesions of lymph nodes, spleen and bone marrow, among them 9 were diagnosed as non-Hodgkin's lymphoma, 4 were not finally diagnosed. Nonmalignant lesions were found in 6 patients with ^18F-FDG PET/CT, among them 2 were diagnosed as systemic lupus erythematosus, 1 as Epstein-Barr virus infection, 1 as ulcerative colitis, 1 as adult onset Still's disease, and 1 was not finally diagnosed. Three patients of lymphoma-associatied hemophagocytic syndrome were monitored by ^18F-FDG PET/CT, present as disappearance of high metabolic lesions when clinical symptoms improved, but appearances of new high metabolic lesions when the disease relapsed. Conclusion ^18F-FDG PET/CT is of great value in diagnosing primary disease of secondary hemophagocytic syndrome, especially in differentiating benign and malignant lesions. In addition, ^18F-FDG PET/CT is useful for monitoring the progresses of primary disease.
出处 《中国医学影像技术》 CSCD 北大核心 2014年第5期780-783,共4页 Chinese Journal of Medical Imaging Technology
关键词 淋巴组织细胞增多症 噬血细胞性 淋巴瘤 正电子发射型体层摄影术 氟脱氧葡萄糖F18 Lymphohistiocytosis, hemophagocytic Lymphoma Positron-emission tomography Fluorodeoxyglucose F18
  • 引文网络
  • 相关文献

参考文献15

  • 1Gholam C, Grigoriadou S, Gilmour KC, et al. Familial haemophago- eytie lymphohistioeytosis: Advances in the genetic basis, diagnosis and management, Clin Exp Immunol, 2011,163(3) :271-283.
  • 2Janka GE. Familial and acquired hemophagoeytic lymphohistiocy- tosis. Eur J pediatr, 2007,166(2) :95-109.
  • 3王晶石,王昭,吴林,陈皙,冯翠翠.38例噬血细胞综合征病因分析[J].中国实验血液学杂志,2010,18(5):1316-1320. 被引量:11
  • 4王旖旎,王昭,吴林,岑溪南,李渤涛,宁丰,段学章,李娟.多中心72例噬血细胞综合征诊疗分析[J].中华血液学杂志,2009,30(12):793-798. 被引量:98
  • 5肖莉,宪莹,戴碧涛,苏庸春,肖剑文,郑启城,赵晓东,于洁.HLH-2004方案治疗83例EB病毒相关噬血淋巴组织细胞增生症患儿疗效分析[J].中华血液学杂志,2011,32(10):668-672. 被引量:24
  • 6Henter J, Samuelsson-Horne A, Arico M, et al. Treatment of he- mophagoeytic lymphohistioeytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood, 2002,100(7):2367-2373.
  • 7Celkan T, Berrak S, Kazanei E, et al. Malignancy-associated he-mophagocytic lymphohistiocytosis in pediatric cases: A multi- center study from Turkey. Turk J Pediatr, 2009,51 (3) : 207-213.
  • 8Gupta AA, Tyrrell P, Valani R, et al. Experience with hemoph- agocytic lymphohistiocytosis/macrophage activation syndrome at a single institution. Pediatr Hematol Oncol, 2009,31(2):81-84.
  • 9Han AR, Lee HR, Park BB, et al. Lymphoma-assoeiated he- mophagocytic syndrome: Clinical features and treatment out- come. Ann Hematol, 2007,86(7) :493-498.
  • 10Tong H, Ren Y, Liu H, et al. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: Compari- son of T-cell lymphoma with and without hemophagocytic syn- drome. Leuk Lymphoma, 2008,49(1) :81-87.

二级参考文献51

共引文献127

同被引文献43

  • 1Zhang L,Zhou J,Sokol L.Hereditary and acquired hemophagocytic lymphohistiocytosis[J].Cancer Control,2014,21:301-312.
  • 2Otrock ZK,Eby CS.Clinical characteristics,prognostic factors,and outcomes of adult patients with hemophagocytic lymphohistiocytosis[J].Am J Hematol,2015,90:220-224.
  • 3Ishii E,Ohga S,Imashuku S,et al.Nationwide survey of hemophagocytic lymphohistiocytosis in Japan[J].Int J Hematol,2007,86:58-65.
  • 4Parikh SA,Kapoor P,Letendre L,et al.Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis[J].Mayo Clin Proc,2014,89:484-492.
  • 5Rivière S,Galicier L,Coppo P,et al.Reactive hemophagocytic syndrome in adults:a retrospective analysis of162patients[J].Am J Med,2014,127:1118-1125.
  • 6Lehmberg K,Sprekels B,Nichols KE,et al.Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents[J].Br J Haematol,2015,170:539-549.
  • 7Lehmberg K,Nichols KE,Henter JI,et al.Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies[J].Haematologica,2015,100:997-1004.
  • 8Usmani GN,Woda BA,Newburger PE.Advances in understanding the pathogenesis of HLH[J].Br J Haematol,2013,161:609-622.
  • 9Janka GE,Lehmberg K.Hemophagocytic lymphohistiocytosis:pathogenesis and treatment[J].Hematology Am Soc Hematol Educ Program,2013,2013:605-611.
  • 10Janka GE,Lehmberg K.Hemophagocytic syndromes--an update[J].Blood Rev,2014,28:135-142.

引证文献2

二级引证文献9

;
使用帮助 返回顶部